<DOC>
	<DOCNO>NCT01177826</DOCNO>
	<brief_summary>The purpose study assess vaccine effectiveness Rotarix prevent rotavirus severe gastroenteritis among hospitalized infant , Belgium .</brief_summary>
	<brief_title>Effectiveness Study GSK Biologicals ' Rotarix TM Vaccine Hospitalized Children</brief_title>
	<detailed_description />
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Rotavirus Infections</mesh_term>
	<criteria>For confirm case : A male female child bear 01 October 2006 least 14 week age time hospital admission . Child admit study hospital SGE study period . Onset SGE ≤ 14 day prior admission . Written inform consent obtain sign parent guardian child . Stool sample collect first 48 hour hospitalisation test positive RV PCR . For control : A male female child bear 01 October 2006 least 14 week age time hospital admission visit hospital outpatient clinic . Hospitalised visit hospital outpatient clinic nonGE cause hospital timeperiod , probable case . Born within ±2 week date birth case . If list child bear within ±2 week exhaust , range extend ±4 week . In case suitable control find even , range extend ±6 week . Written inform consent obtain sign parent guardian child . For case : Child previously participate case control study , either hospital another study hospital . Onset SGE &gt; 48 hour admission hospital ( nosocomial infection ) . Child condition rotavirus vaccination would contraindicate . For control : Child participate past case control study , either hospital another study hospital . Child symptom GE/ SGE current hospital stay/ visit hospital outpatient clinic day interview his/her parent guardian . Child condition rotavirus vaccination would contraindicate .</criteria>
	<gender>All</gender>
	<minimum_age>14 Weeks</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Hospitalized</keyword>
	<keyword>Rotavirus</keyword>
	<keyword>Children</keyword>
	<keyword>effectiveness</keyword>
	<keyword>Gastroenteritis</keyword>
</DOC>